Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bleomycin
- Development stage
- Approved
- Lead developer
- Bristol Laboratories
- Modality
- Small Molecules
- Administration
- Intravenous, Intramuscular, Subcutaneous, Intrapleural
01
Overview
Bleomycin is an antitumor antibiotic derived from the bacterium Streptomyces verticillus. It is primarily used in the treatment of various cancers including Hodgkin lymphoma, non-Hodgkin lymphoma, testicular cancer, ovarian cancer, and cervical cancer. It may also be used for pleurodesis in malignant pleural effusions and occasionally for treating warts. Bleomycin acts by binding to DNA and causing strand breaks through free radical formation and inhibition of DNA synthesis. This leads to apoptosis (cell death) in rapidly dividing cells such as cancer cells. The drug is usually administered intravenously, intramuscularly, subcutaneously or intrapleurally. Common side effects include fever, weight loss, vomiting and skin rash; a serious risk is pulmonary toxicity leading to lung fibrosis[1][2][3].
- Brand names
- BlenoxaneBleocel
- Other names
- 博来霉素博莱霉素争光霉素bleo
02
Targets
DNA
Beyond the preview
Go deeper on bleomycin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bleomycin.